{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:53:49Z","timestamp":1790704429558,"version":"4.1.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Despite growing awareness that disclosing biomarker results to research participants is aligned with ethical principles of researcher-participant partnership, there are currently no widely adopted guidelines for this disclosure in Alzheimer's disease research. We developed a process and tools to deliver biomarker and genetic results to 65 participants of The Memory and Aging Study of the Duke-UNC Alzheimer's Disease Research Center (ADRC). Survey responses of 46 participants were analyzed. We show high participant satisfaction and lower anxiety levels after receiving the results. The developed process and materials provide a template for standardized Alzheimer's disease biomarker result delivery in the research setting.<\/jats:p>","DOI":"10.1177\/13872877251315957","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T01:26:51Z","timestamp":1739150811000},"page":"312-318","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Genetic and biomarker disclosure process in a memory and aging study"],"prefix":"10.1177","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-5799","authenticated-orcid":false,"given":"Inbal","family":"Mayan","sequence":"first","affiliation":[{"name":"Duke Aging Center and Department of Medicine, Duke University School of Medicine, Durham, NC, USA"},{"name":"Global Brain Health Institute, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9038-6173","authenticated-orcid":false,"given":"Heidi","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-3786","authenticated-orcid":false,"given":"Dhrubajyoti","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8417-4846","authenticated-orcid":false,"given":"Heather E","family":"Whitson","sequence":"additional","affiliation":[{"name":"Duke Aging Center and Department of Medicine, Duke University School of Medicine, Durham, NC, USA"},{"name":"Geriatrics Research Education and Clinical Center, Durham VA, USA"},{"name":"VA Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-2489","authenticated-orcid":false,"given":"Kim G","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,2,9]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002923"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207978"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1285"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220810"},{"key":"e_1_3_5_6_2","volume-title":"Enhancing public access to the results of research supported by the department of health and human services: proceedings of a workshop-in brief","author":"Board on Health Sciences Policy","year":"2024","unstructured":"Board on Health Sciences Policy, Board on Research Data and Information, Health and Medicine Division, et al. Enhancing public access to the results of research supported by the department of health and human services: proceedings of a workshop-in brief. Washington, DC: National Academies Press, 2024."},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2200-4"},{"key":"e_1_3_5_8_2","article-title":"Disclosure of individual research results at federally funded Alzheimer\u2019s Disease Research Centers","volume":"7","author":"Roberts JS","year":"2021","unstructured":"Roberts JS, Ferber R, Blacker D, et al. Disclosure of individual research results at federally funded Alzheimer\u2019s Disease Research Centers. Alzheimers Dement (N Y) 2021; 7: e12213.","journal-title":"Alzheimers Dement (N Y)"},{"key":"e_1_3_5_9_2","unstructured":"Department of Health and Human Services RFA for NIA-funded ADRCs https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-AG-24-001.html (2023 accessed 14 October 2024)."},{"key":"e_1_3_5_10_2","unstructured":"National Alzheimer\u2019s Coordinating Center (NACC) best practice guidance on biomarker disclosure https:\/\/naccdata.org\/adrc-resources\/best-practices (accessed 14 October 2024)."},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.101"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnac051"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13410"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230275"},{"key":"e_1_3_5_15_2","article-title":"Implications of preclinical Alzheimer\u2019s disease biomarker disclosure for US policy and society","volume":"14","author":"Erickson CM","year":"2022","unstructured":"Erickson CM, Clark LR, Ketchum FB, et al. Implications of preclinical Alzheimer\u2019s disease biomarker disclosure for US policy and society. Alzheimers Dement (Amst) 2022; 14: e12339.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180629"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13380"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12630"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150985"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.11.007"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14668"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000206891"},{"key":"e_1_3_5_23_2","unstructured":"National Alzheimer\u2019s Coordinating Center (NACC) forms and documentation UDS3 https:\/\/naccdata.org\/data-collection\/forms-documentation\/uds-3 (accessed 14 October 2024)."},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-230359"},{"key":"e_1_3_5_25_2","article-title":"Disclosure of preclinical Alzheimer\u2019s disease biomarker results in research and clinical settings: why, how, and what we still need to know","volume":"13","author":"Erickson CM","year":"2021","unstructured":"Erickson CM, Chin NA, Johnson SC, et al. Disclosure of preclinical Alzheimer\u2019s disease biomarker results in research and clinical settings: why, how, and what we still need to know. Alzheimers Dement (Amst) 2021; 13: e12150.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2734"},{"key":"e_1_3_5_27_2","article-title":"Feasibility of virtual Alzheimer\u2019s biomarker disclosure: findings from an observational cohort","volume":"9","author":"Erickson CM","year":"2023","unstructured":"Erickson CM, Chin NA, Rosario HL, et al. Feasibility of virtual Alzheimer\u2019s biomarker disclosure: findings from an observational cohort. Alzheimers Dement (N Y) 2023; 9: e12413.","journal-title":"Alzheimers Dement (N Y)"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251315957","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13872877251315957","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13872877251315957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:48Z","timestamp":1777370988000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13872877251315957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,9]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1177\/13872877251315957"],"URL":"https:\/\/doi.org\/10.1177\/13872877251315957","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,9]]}}}